Global Superdisintegrants Market: Industry Analysis and Forecast (2019-2026) –By Product Type, Formulation, Therapeutic Area and Region.

Global superdisintegrants market size was valued at US$ 312.52 Mn in 2019 and is expected to reach US$ 562.3 Mn by 2026 to exhibit a CAGR of 7.62 % during a forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
To know about the Research Methodology:-Request Free Sample Report

Global Superdisintegrants Market Dynamics:

Disintegrants are mixture used to prepare tablets formulation to ensure the rapid break down into smaller particles that facilitate the dissolution more rapidly and release of the active ingredients. Rising adoption of orally disintegrating tablets and the emergence of new superisintegrants for the pharmaceutical industry are increasing the growth of the market. Pharmaceutical market expansion in emerging countries is a key opportunity of the market. However, safety and quality concerns are limiting the growth of the superdisintegrants market. The synthetic superdisintegrant segment held the largest share of the global superdisintegrants market owing to the prevalent use of excipients such as sodium starch glycolate, and crospovidone in orally & fast disintegrating tablets. Increasing incidences of cardiac diseases, neurological infections are also expected to drive the demand of synthetic segment in global superdisintegrants market. Although synthetic superdisintegrants have been the ordinary for many decades now, greater research into natural superdisintegrants will drive for the future growth of the superdisintegrants market. Natural polymers will drive the market growth during the forecast period owing to the increased solubility of poorly water soluble drug. Natural polymers increase the properties of the tablet due to the presence of natural polymers such as Mangifera indica gum, Hibiscus Rosa sinenses mucilage, dehydrated banana powder, orange peel pectin, and Locust bean gum. The tablets segment is estimated to account for the largest share of the superdisintegrants market owing to the rising stability, low manufacturing cost as compared to other dosage forms such as capsules, and mouth-dissolving films. Easy product identification and solidity of the product are driving the production of tablet formulations. Moreover, an increasing focus on fast and orally disintegrating tablets are also contributing to the large share of tablets segment in the superdisintegrants market. The neurological diseases segment is projected to the largest share in 2019, owing to the growing incidences of neurological disorders has led to a rise in the demand for effective therapies, which has further led to the increasing use of over-the-counter in the treatment of neurological disorders. Gastrointestinal diseases include the diseases namely the oesophagus, stomach, small intestine, large intestine and rectum. Gastrointestinal diseases are becoming more common in the developing region, with symptoms like nausea, vomiting, abdominal pain, reduced appetite, bloating, swallowing difficulties, and heartburn. North America is leading the market owing to the growing financial support for the development of innovative oral dosage forms. The Asia Pacific is expected to grow the fastest rate during the forecast period owing to the growing healthcare spending, increasing healthcare infrastructure & awareness and rising outsourcing of excipient manufacturing to Asia Pacific countries such as India & China. Low-cost manufacturing advantage, growing per capita income, low regulatory stringency, and rising interest of key players in APAC countries are also expected to grow the market in this region. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding global superdisintegrants market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in global superdisintegrants market.

Global Superdisintegrants Market, Key Highlights:

• Global Superdisintegrants Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Superdisintegrants Market • Global Superdisintegrants Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Global Superdisintegrants Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Global Superdisintegrants Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Superdisintegrants Market are also profiled. The report has considered the base year of 2019 and past four years trend. 2020 figures are at actuals, however due to different dynamics of year 2020, market forecast is not only dependent upon 2020, but on the basis of 2016-2020.

The Scope of Global Superdisintegrants Market: Inquire before buying

Global Superdisintegrants Market, By Product Type:

• Natural Superdisintegrants • Synthetic Superdisintegrants • Other

Global Superdisintegrants Market, By Formulation:

• Tablets • Capsules • Mouth-dissolving Films

Global Superdisintegrants Market, By Therapeutic Area:

• Gastrointestinal Diseases • Neurological Diseases • Oncology • Infectious Diseases • Cardiovascular Diseases • Hematological Diseases • Inflammatory Diseases

Global Superdisintegrants Market, By Region:

• North America • Europe • Middle East & Africa • Asia Pacific • South America

The Key Players Operating In the Global Superdisintegrants Market:

• Ashland • BASF SE • FMC Corporation • JRS Pharma • DFE Pharma • Roquette • The Dow Chemical Company • Asahi Kasei Corporation • Nippon Soda Co • Huber Corporation • DowDuPont • Merck KGaA • Corel Pharma Chem • Avantor Performance Materials, LLC

Global superdisintegrants market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Superdisintegrants Market Size, by Market Value (US$ Mn) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies in Global Superdisintegrants Market 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Superdisintegrants Market Analysis and Forecast 6.1. Global Superdisintegrants Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Superdisintegrants Market Analysis and Forecast, by Product Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Superdisintegrants Market Value Share Analysis, by Product Type 7.4. Global Superdisintegrants Market Size (US$ Mn) Forecast, by Product Type 7.5. Global Superdisintegrants Market Analysis, by Product Type 7.6. Global Superdisintegrants Market Attractiveness Analysis, by Product Type 8. Global Superdisintegrants Market Analysis and Forecast, by Formulation 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Superdisintegrants Market Value Share Analysis, by Formulation 8.4. Global Superdisintegrants Market Size (US$ Mn) Forecast, by Formulation 8.5. Global Superdisintegrants Market Analysis, by Formulation 8.6. Global Superdisintegrants Market Attractiveness Analysis, by Formulation 9. Global Superdisintegrants Market Analysis and Forecast, by Therapeutic Area 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Superdisintegrants Market Value Share Analysis, by Therapeutic Area 9.4. Global Superdisintegrants Market Size (US$ Mn) Forecast, by Therapeutic Area 9.5. Global Superdisintegrants Market Analysis, by Therapeutic Area 9.6. Global Superdisintegrants Market Attractiveness Analysis, by Therapeutic Area 10. Global Superdisintegrants Market Analysis, by Region 10.1. Global Superdisintegrants Market Value Share Analysis, by Region 10.2. Global Superdisintegrants Market Size (US$ Mn) Forecast, by Region 10.3. Global Superdisintegrants Market Attractiveness Analysis, by Region 11. North America Superdisintegrants Market Analysis 11.1. Key Findings 11.2. North America Superdisintegrants Market Overview 11.3. North America Superdisintegrants Market Value Share Analysis, by Product Type 11.4. North America Superdisintegrants Market Forecast, by Product Type 11.4.1. Natural Superdisintegrants 11.4.2. Synthetic Superdisintegrants 11.4.3. Other 11.5. North America Superdisintegrants Market Value Share Analysis, by Formulation 11.6. North America Superdisintegrants Market Forecast, by Formulation 11.6.1. Tablets 11.6.2. Capsules 11.6.3. Mouth-dissolving Films 11.7. North America Superdisintegrants Market Value Share Analysis, by Therapeutic Area 11.8. North America Superdisintegrants Market Forecast, by Therapeutic Area 11.8.1. Gastrointestinal Diseases 11.8.2. Neurological Diseases 11.8.3. Oncology 11.8.4. Infectious Diseases 11.8.5. Cardiovascular Diseases 11.8.6. Hematological Diseases 11.8.7. Inflammatory Diseases 11.9. North America Superdisintegrants Market Value Share Analysis, by Country 11.10. North America Superdisintegrants Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Superdisintegrants Market Analysis, by Country 11.12. U.S. Superdisintegrants Market Forecast, by Product Type 11.12.1. Natural Superdisintegrants 11.12.2. Synthetic Superdisintegrants 11.12.3. Other 11.13. U.S. Superdisintegrants Market Forecast, by Formulation 11.13.1. Tablets 11.13.2. Capsules 11.13.3. Mouth-dissolving Films 11.14. U.S. Superdisintegrants Market Forecast, by Therapeutic Area 11.14.1. Gastrointestinal Diseases 11.14.2. Neurological Diseases 11.14.3. Oncology 11.14.4. Infectious Diseases 11.14.5. Cardiovascular Diseases 11.14.6. Hematological Diseases 11.14.7. Inflammatory Diseases 11.15. Canada Superdisintegrants Market Forecast, by Product Type 11.15.1. Natural Superdisintegrants 11.15.2. Synthetic Superdisintegrants 11.15.3. Other 11.16. Canada Superdisintegrants Market Forecast, by Formulation 11.16.1. Tablets 11.16.2. Capsules 11.16.3. Mouth-dissolving Films 11.17. Canada Superdisintegrants Market Forecast, by Therapeutic Area 11.17.1. Gastrointestinal Diseases 11.17.2. Neurological Diseases 11.17.3. Oncology 11.17.4. Infectious Diseases 11.17.5. Cardiovascular Diseases 11.17.6. Hematological Diseases 11.17.7. Inflammatory Diseases 11.18. North America Superdisintegrants Market Attractiveness Analysis 11.18.1. By Product Type 11.18.2. By Formulation 11.18.3. By Therapeutic Area 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Superdisintegrants Market Analysis 12.1. Key Findings 12.2. Europe Superdisintegrants Market Overview 12.3. Europe Superdisintegrants Market Value Share Analysis, by Product Type 12.4. Europe Superdisintegrants Market Forecast, by Product Type 12.4.1. Natural Superdisintegrants 12.4.2. Synthetic Superdisintegrants 12.4.3. Other 12.5. Europe Superdisintegrants Market Value Share Analysis, by Formulation 12.6. Europe Superdisintegrants Market Forecast, by Formulation 12.6.1. Tablets 12.6.2. Capsules 12.6.3. Mouth-dissolving Films 12.7. Europe Superdisintegrants Market Value Share Analysis, by Therapeutic Area 12.8. Europe Superdisintegrants Market Forecast, by Therapeutic Area 12.8.1. Gastrointestinal Diseases 12.8.2. Neurological Diseases 12.8.3. Oncology 12.8.4. Infectious Diseases 12.8.5. Cardiovascular Diseases 12.8.6. Hematological Diseases 12.8.7. Inflammatory Diseases 12.9. Europe Superdisintegrants Market Value Share Analysis, by Country 12.10. Europe Superdisintegrants Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Superdisintegrants Market Analysis, by Country 12.12. Germany Superdisintegrants Market Forecast, by Product Type 12.12.1. Natural Superdisintegrants 12.12.2. Synthetic Superdisintegrants 12.12.3. Other 12.13. Germany Superdisintegrants Market Forecast, by Formulation 12.13.1. Tablets 12.13.2. Capsules 12.13.3. Mouth-dissolving Films 12.14. Germany Superdisintegrants Market Forecast, by Therapeutic Area 12.14.1. Gastrointestinal Diseases 12.14.2. Neurological Diseases 12.14.3. Oncology 12.14.4. Infectious Diseases 12.14.5. Cardiovascular Diseases 12.14.6. Hematological Diseases 12.14.7. Inflammatory Diseases 12.15. U.K. Superdisintegrants Market Forecast, by Product Type 12.15.1. Natural Superdisintegrants 12.15.2. Synthetic Superdisintegrants 12.15.3. Other 12.16. U.K. Superdisintegrants Market Forecast, by Formulation 12.16.1. Tablets 12.16.2. Capsules 12.16.3. Mouth-dissolving Films 12.17. U.K. Superdisintegrants Market Forecast, by Therapeutic Area 12.17.1. Gastrointestinal Diseases 12.17.2. Neurological Diseases 12.17.3. Oncology 12.17.4. Infectious Diseases 12.17.5. Cardiovascular Diseases 12.17.6. Hematological Diseases 12.17.7. Inflammatory Diseases 12.18. France Superdisintegrants Market Forecast, by Product Type 12.18.1. Natural Superdisintegrants 12.18.2. Synthetic Superdisintegrants 12.18.3. Other 12.19. France Superdisintegrants Market Forecast, by Formulation 12.19.1. Tablets 12.19.2. Capsules 12.19.3. Mouth-dissolving Films 12.20. France Superdisintegrants Market Forecast, by Therapeutic Area 12.20.1. Gastrointestinal Diseases 12.20.2. Neurological Diseases 12.20.3. Oncology 12.20.4. Infectious Diseases 12.20.5. Cardiovascular Diseases 12.20.6. Hematological Diseases 12.20.7. Inflammatory Diseases 12.21. Italy Superdisintegrants Market Forecast, by Product Type 12.21.1. Natural Superdisintegrants 12.21.2. Synthetic Superdisintegrants 12.21.3. Other 12.22. Italy Superdisintegrants Market Forecast, by Formulation 12.22.1. Tablets 12.22.2. Capsules 12.22.3. Mouth-dissolving Films 12.23. Italy Superdisintegrants Market Forecast, by Therapeutic Area 12.23.1. Gastrointestinal Diseases 12.23.2. Neurological Diseases 12.23.3. Oncology 12.23.4. Infectious Diseases 12.23.5. Cardiovascular Diseases 12.23.6. Hematological Diseases 12.23.7. Inflammatory Diseases 12.24. Spain Superdisintegrants Market Forecast, by Product Type 12.24.1. Natural Superdisintegrants 12.24.2. Synthetic Superdisintegrants 12.24.3. Other 12.25. Spain Superdisintegrants Market Forecast, by Formulation 12.25.1. Tablets 12.25.2. Capsules 12.25.3. Mouth-dissolving Films 12.26. Spain Superdisintegrants Market Forecast, by Therapeutic Area 12.26.1. Gastrointestinal Diseases 12.26.2. Neurological Diseases 12.26.3. Oncology 12.26.4. Infectious Diseases 12.26.5. Cardiovascular Diseases 12.26.6. Hematological Diseases 12.26.7. Inflammatory Diseases 12.27. Rest of Europe Superdisintegrants Market Forecast, by Product Type 12.27.1. Natural Superdisintegrants 12.27.2. Synthetic Superdisintegrants 12.27.3. Other 12.28. Rest of Europe Superdisintegrants Market Forecast, by Formulation 12.28.1. Tablets 12.28.2. Capsules 12.28.3. Mouth-dissolving Films 12.29. Rest of Europe Superdisintegrants Market Forecast, by Therapeutic Area 12.29.1. Gastrointestinal Diseases 12.29.2. Neurological Diseases 12.29.3. Oncology 12.29.4. Infectious Diseases 12.29.5. Cardiovascular Diseases 12.29.6. Hematological Diseases 12.29.7. Inflammatory Diseases 12.30. Europe Superdisintegrants Market Attractiveness Analysis 12.30.1. By Product Type 12.30.2. By Formulation 12.30.3. By Therapeutic Area 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Superdisintegrants Market Analysis 13.1. Key Findings 13.2. Asia Pacific Superdisintegrants Market Overview 13.3. Asia Pacific Superdisintegrants Market Value Share Analysis, by Product Type 13.4. Asia Pacific Superdisintegrants Market Forecast, by Product Type 13.4.1. Natural Superdisintegrants 13.4.2. Synthetic Superdisintegrants 13.4.3. Other 13.5. Asia Pacific Superdisintegrants Market Value Share Analysis, by Formulation 13.6. Asia Pacific Superdisintegrants Market Forecast, by Formulation 13.6.1. Tablets 13.6.2. Capsules 13.6.3. Mouth-dissolving Films 13.7. Asia Pacific Superdisintegrants Market Value Share Analysis, by Therapeutic Area 13.8. Asia Pacific Superdisintegrants Market Forecast, by Therapeutic Area 13.8.1. Gastrointestinal Diseases 13.8.2. Neurological Diseases 13.8.3. Oncology 13.8.4. Infectious Diseases 13.8.5. Cardiovascular Diseases 13.8.6. Hematological Diseases 13.8.7. Inflammatory Diseases 13.9. Asia Pacific Superdisintegrants Market Value Share Analysis, by Country 13.10. Asia Pacific Superdisintegrants Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Superdisintegrants Market Analysis, by Country 13.12. China Superdisintegrants Market Forecast, by Product Type 13.12.1. Natural Superdisintegrants 13.12.2. Synthetic Superdisintegrants 13.12.3. Other 13.13. China Superdisintegrants Market Forecast, by Formulation 13.13.1. Tablets 13.13.2. Capsules 13.13.3. Mouth-dissolving Films 13.14. China Superdisintegrants Market Forecast, by Therapeutic Area 13.14.1. Gastrointestinal Diseases 13.14.2. Neurological Diseases 13.14.3. Oncology 13.14.4. Infectious Diseases 13.14.5. Cardiovascular Diseases 13.14.6. Hematological Diseases 13.14.7. Inflammatory Diseases 13.15. India Superdisintegrants Market Forecast, by Product Type 13.15.1. Natural Superdisintegrants 13.15.2. Synthetic Superdisintegrants 13.15.3. Other 13.16. India Superdisintegrants Market Forecast, by Formulation 13.16.1. Tablets 13.16.2. Capsules 13.16.3. Mouth-dissolving Films 13.17. India Superdisintegrants Market Forecast, by Therapeutic Area 13.17.1. Gastrointestinal Diseases 13.17.2. Neurological Diseases 13.17.3. Oncology 13.17.4. Infectious Diseases 13.17.5. Cardiovascular Diseases 13.17.6. Hematological Diseases 13.17.7. Inflammatory Diseases 13.18. Japan Superdisintegrants Market Forecast, by Product Type 13.18.1. Natural Superdisintegrants 13.18.2. Synthetic Superdisintegrants 13.18.3. Other 13.19. Japan Superdisintegrants Market Forecast, by Formulation 13.19.1. Tablets 13.19.2. Capsules 13.19.3. Mouth-dissolving Films 13.20. Japan Superdisintegrants Market Forecast, by Therapeutic Area 13.20.1. Gastrointestinal Diseases 13.20.2. Neurological Diseases 13.20.3. Oncology 13.20.4. Infectious Diseases 13.20.5. Cardiovascular Diseases 13.20.6. Hematological Diseases 13.20.7. Inflammatory Diseases 13.21. ASEAN Superdisintegrants Market Forecast, by Product Type 13.21.1. Natural Superdisintegrants 13.21.2. Synthetic Superdisintegrants 13.21.3. Other 13.22. ASEAN Superdisintegrants Market Forecast, by Formulation 13.22.1. Tablets 13.22.2. Capsules 13.22.3. Mouth-dissolving Films 13.23. ASEAN Superdisintegrants Market Forecast, by Therapeutic Area 13.23.1. Gastrointestinal Diseases 13.23.2. Neurological Diseases 13.23.3. Oncology 13.23.4. Infectious Diseases 13.23.5. Cardiovascular Diseases 13.23.6. Hematological Diseases 13.23.7. Inflammatory Diseases 13.24. Rest of Asia Pacific Superdisintegrants Market Forecast, by Product Type 13.24.1. Natural Superdisintegrants 13.24.2. Synthetic Superdisintegrants 13.24.3. Other 13.25. Rest of Asia Pacific Superdisintegrants Market Forecast, by Formulation 13.25.1. Tablets 13.25.2. Capsules 13.25.3. Mouth-dissolving Films 13.26. Rest of Asia Pacific Superdisintegrants Market Forecast, by Therapeutic Area 13.26.1. Gastrointestinal Diseases 13.26.2. Neurological Diseases 13.26.3. Oncology 13.26.4. Infectious Diseases 13.26.5. Cardiovascular Diseases 13.26.6. Hematological Diseases 13.26.7. Inflammatory Diseases 13.27. Asia Pacific Superdisintegrants Market Attractiveness Analysis 13.27.1. By Product Type 13.27.2. By Formulation 13.27.3. By Therapeutic Area 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Superdisintegrants Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Superdisintegrants Market Overview 14.3. Middle East & Africa Superdisintegrants Market Value Share Analysis, by Product Type 14.4. Middle East & Africa Superdisintegrants Market Forecast, by Product Type 14.4.1. Natural Superdisintegrants 14.4.2. Synthetic Superdisintegrants 14.4.3. Other 14.5. Middle East & Africa Superdisintegrants Market Value Share Analysis, by Formulation 14.6. Middle East & Africa Superdisintegrants Market Forecast, by Formulation 14.6.1. Tablets 14.6.2. Capsules 14.6.3. Mouth-dissolving Films 14.7. Middle East & Africa Superdisintegrants Market Value Share Analysis, by Therapeutic Area 14.8. Middle East & Africa Superdisintegrants Market Forecast, by Therapeutic Area 14.8.1. Gastrointestinal Diseases 14.8.2. Neurological Diseases 14.8.3. Oncology 14.8.4. Infectious Diseases 14.8.5. Cardiovascular Diseases 14.8.6. Hematological Diseases 14.8.7. Inflammatory Diseases 14.9. Middle East & Africa Superdisintegrants Market Value Share Analysis, by Country 14.10. Middle East & Africa Superdisintegrants Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Superdisintegrants Market Analysis, by Country 14.12. GCC Superdisintegrants Market Forecast, by Product Type 14.12.1. Natural Superdisintegrants 14.12.2. Synthetic Superdisintegrants 14.12.3. Other 14.13. GCC Superdisintegrants Market Forecast, by Formulation 14.13.1. Tablets 14.13.2. Capsules 14.13.3. Mouth-dissolving Films 14.14. GCC Superdisintegrants Market Forecast, by Therapeutic Area 14.14.1. Gastrointestinal Diseases 14.14.2. Neurological Diseases 14.14.3. Oncology 14.14.4. Infectious Diseases 14.14.5. Cardiovascular Diseases 14.14.6. Hematological Diseases 14.14.7. Inflammatory Diseases 14.15. South Africa Superdisintegrants Market Forecast, by Product Type 14.15.1. Natural Superdisintegrants 14.15.2. Synthetic Superdisintegrants 14.15.3. Other 14.16. South Africa Superdisintegrants Market Forecast, by Formulation 14.16.1. Tablets 14.16.2. Capsules 14.16.3. Mouth-dissolving Films 14.17. South Africa Superdisintegrants Market Forecast, by Therapeutic Area 14.17.1. Gastrointestinal Diseases 14.17.2. Neurological Diseases 14.17.3. Oncology 14.17.4. Infectious Diseases 14.17.5. Cardiovascular Diseases 14.17.6. Hematological Diseases 14.17.7. Inflammatory Diseases 14.18. Rest of Middle East & Africa Superdisintegrants Market Forecast, by Product Type 14.18.1. Natural Superdisintegrants 14.18.2. Synthetic Superdisintegrants 14.18.3. Other 14.19. Rest of Middle East & Africa Superdisintegrants Market Forecast, by Formulation 14.19.1. Tablets 14.19.2. Capsules 14.19.3. Mouth-dissolving Films 14.20. Rest of Middle East & Africa Superdisintegrants Market Forecast, by Therapeutic Area 14.20.1. Gastrointestinal Diseases 14.20.2. Neurological Diseases 14.20.3. Oncology 14.20.4. Infectious Diseases 14.20.5. Cardiovascular Diseases 14.20.6. Hematological Diseases 14.20.7. Inflammatory Diseases 14.21. Middle East & Africa Superdisintegrants Market Attractiveness Analysis 14.21.1. By Product Type 14.21.2. By Formulation 14.21.3. By Therapeutic Area 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Superdisintegrants Market Analysis 15.1. Key Findings 15.2. South America Superdisintegrants Market Overview 15.3. South America Superdisintegrants Market Value Share Analysis, by Product Type 15.4. South America Superdisintegrants Market Forecast, by Product Type 15.4.1. Natural Superdisintegrants 15.4.2. Synthetic Superdisintegrants 15.4.3. Other 15.5. South America Superdisintegrants Market Value Share Analysis, by Formulation 15.6. South America Superdisintegrants Market Forecast, by Formulation 15.6.1. Tablets 15.6.2. Capsules 15.6.3. Mouth-dissolving Films 15.7. South America Superdisintegrants Market Value Share Analysis, by Therapeutic Area 15.8. South America Superdisintegrants Market Forecast, by Therapeutic Area 15.8.1. Gastrointestinal Diseases 15.8.2. Neurological Diseases 15.8.3. Oncology 15.8.4. Infectious Diseases 15.8.5. Cardiovascular Diseases 15.8.6. Hematological Diseases 15.8.7. Inflammatory Diseases 15.9. South America Superdisintegrants Market Value Share Analysis, by Country 15.10. South America Superdisintegrants Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Superdisintegrants Market Analysis, by Country 15.12. Brazil Superdisintegrants Market Forecast, by Product Type 15.12.1. Natural Superdisintegrants 15.12.2. Synthetic Superdisintegrants 15.12.3. Other 15.13. Brazil Superdisintegrants Market Forecast, by Formulation 15.13.1. Tablets 15.13.2. Capsules 15.13.3. Mouth-dissolving Films 15.14. Brazil Superdisintegrants Market Forecast, by Therapeutic Area 15.14.1. Gastrointestinal Diseases 15.14.2. Neurological Diseases 15.14.3. Oncology 15.14.4. Infectious Diseases 15.14.5. Cardiovascular Diseases 15.14.6. Hematological Diseases 15.14.7. Inflammatory Diseases 15.15. Mexico Superdisintegrants Market Forecast, by Product Type 15.15.1. Natural Superdisintegrants 15.15.2. Synthetic Superdisintegrants 15.15.3. Other 15.16. Mexico Superdisintegrants Market Forecast, by Formulation 15.16.1. Tablets 15.16.2. Capsules 15.16.3. Mouth-dissolving Films 15.17. Mexico Superdisintegrants Market Forecast, by Therapeutic Area 15.17.1. Gastrointestinal Diseases 15.17.2. Neurological Diseases 15.17.3. Oncology 15.17.4. Infectious Diseases 15.17.5. Cardiovascular Diseases 15.17.6. Hematological Diseases 15.17.7. Inflammatory Diseases 15.18. Rest of South America Superdisintegrants Market Forecast, by Product Type 15.18.1. Natural Superdisintegrants 15.18.2. Synthetic Superdisintegrants 15.18.3. Other 15.19. Rest of South America Superdisintegrants Market Forecast, by Formulation 15.19.1. Tablets 15.19.2. Capsules 15.19.3. Mouth-dissolving Films 15.20. Rest of South America Superdisintegrants Market Forecast, by Therapeutic Area 15.20.1. Gastrointestinal Diseases 15.20.2. Neurological Diseases 15.20.3. Oncology 15.20.4. Infectious Diseases 15.20.5. Cardiovascular Diseases 15.20.6. Hematological Diseases 15.20.7. Inflammatory Diseases 15.21. South America Superdisintegrants Market Attractiveness Analysis 15.21.1. By Product Type 15.21.2. By Formulation 15.21.3. By Therapeutic Area 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Ashland 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Manufacturing 16.3.2. BASF SE 16.3.3. FMC Corporation 16.3.4. JRS Pharma 16.3.5. DFE Pharma 16.3.6. Roquette 16.3.7. The Dow Chemical Company 16.3.8. Asahi Kasei Corporation 16.3.9. Nippon Soda Co 16.3.10. Huber Corporation 16.3.11. DowDuPont 16.3.12. Merck KGaA 16.3.13. Corel Pharma Chem 16.3.14. Avantor Performance Materials, LLC 17. Primary Key Insights

About This Report

Report ID24119
Category Healthcare
Published DateJan 2019
Updated DateAug 2020
Contact Us